to invest $3 billion in the Netherlands to build a new manufacturing facility and expand its oral drug production capacity.
November 4, 2025
Source: drugdu
112
November 3rd, ReiThe company announced plans to acquire Caterpillar in the Netherlands.Vic is investing $3 billion to build a new manufacturing facility to expand its oral drug production capacity and improve its global supply chain. Eli Lilly stated that the facility will be responsible for producing its first oral small-molecule GLP-1 receptor agonist, orforglipron. The company plans to submit applications for the drug's use in obesity treatment to regulatory agencies worldwide by the end of this year.
Eli Lilly also stated that the investment plan will create 500 high-paying jobs in South Holland, targeting highly skilled engineers, scientists, operations specialists, and laboratory technicians. In addition, approximately 1,500 new jobs are expected during construction. The project is scheduled to begin next year, with final implementation depending on the completion of government permits and local approvals.
https://finance.eastmoney.com/a/202511033553774014.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Breaking the Mold and Forging a New Path! From Insulin Technology Pioneer to Global Innovation Competitor December 4, 2025
- A subsidiary of Kingfriend Pharmaceutical Co., Ltd. has received FDA approval for its self-developed injectable dapavancin December 4, 2025
- Major ophthalmic new drug successfully completed Phase III trials December 4, 2025
- Simcere Pharmaceutical and Wangshan Wangshui have reached an exclusive licensing agreement for deuterium remidevir hydrobromide for new indications such as RSV infection December 4, 2025
- SAL0140 tablets approved for clinical trials for the treatment of chronic kidney disease December 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
